UTHR vs. LLY
UTHR (United Therapeutics Corporation) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — UTHR in Biotechnology, LLY in Drug Manufacturers - General. Over the past 10 years, UTHR returned 17.67%/yr vs 33.45%/yr for LLY. At a 0.26 correlation, their price movements are largely independent.
Performance
UTHR vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTHR achieves a 12.05% return, which is significantly higher than LLY's 5.78% return. Over the past 10 years, UTHR has underperformed LLY with an annualized return of 17.67%, while LLY has yielded a comparatively higher 33.45% annualized return.
UTHR
- 1D
- 0.10%
- 1M
- -3.98%
- YTD
- 12.05%
- 6M
- 10.52%
- 1Y
- 92.68%
- 3Y*
- 33.49%
- 5Y*
- 24.97%
- 10Y*
- 17.67%
LLY
- 1D
- -2.41%
- 1M
- 12.75%
- YTD
- 5.78%
- 6M
- 10.64%
- 1Y
- 39.26%
- 3Y*
- 37.45%
- 5Y*
- 39.59%
- 10Y*
- 33.45%
UTHR vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 12.05% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
LLY Eli Lilly and Company | 5.78% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 16.14% | 40.45% | 17.83% |
Correlation
The correlation between UTHR and LLY is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 17, 1999 | 0.26 |
Fundamentals
UTHR:
$25.77B
LLY:
$1.02T
UTHR:
$27.00
LLY:
$28.14
UTHR:
20.22
LLY:
40.26
UTHR:
0.66
LLY:
0.81
UTHR:
8.21
LLY:
14.08
UTHR:
4.37
LLY:
32.54
UTHR:
$3.17B
LLY:
$72.25B
UTHR:
$2.74B
LLY:
$59.75B
UTHR:
$1.75B
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. LLY — Risk / Return Rank
UTHR
LLY
UTHR vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UTHR | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.85 | ||
| Sortino ratioReturn per unit of downside risk | +2.61 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.22 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 8.58 | 1.72 | +6.86 |
| Martin ratioReturn relative to average drawdown | 20.13 | 4.28 | +15.84 |
Loading charts...
Drawdowns
UTHR vs. LLY - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for UTHR and LLY.
Loading charts...
Drawdown Indicators
| UTHR | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -68.24% | -24.94% |
Max Drawdown (1Y)Largest decline over 1 year | -10.64% | -23.64% | +13.00% |
Max Drawdown (3Y)Largest decline over 3 years | -33.00% | -34.48% | +1.48% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -34.48% | +1.48% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | -34.48% | -21.08% |
Current DrawdownCurrent decline from peak | -8.51% | -2.41% | -6.10% |
Average DrawdownAverage peak-to-trough decline | -35.31% | -19.21% | -16.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 9.49% | -4.96% |
Volatility
UTHR vs. LLY - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 5.01%, while Eli Lilly and Company (LLY) has a volatility of 9.27%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTHR | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.01% | 9.27% | -4.26% |
Volatility (6M)Calculated over the trailing 6-month period | 25.94% | 27.16% | -1.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.55% | 38.01% | +9.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.08% | 32.46% | +2.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.06% | 30.19% | +4.87% |
Dividends
UTHR vs. LLY - Dividend Comparison
UTHR has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.57%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.57% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
UTHR vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. LLY - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.
Frequently Asked Questions
UTHR and LLY have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LLY has higher volatility (9.27%) compared to UTHR (5.01%). In terms of maximum drawdown, UTHR dropped -93.18% vs LLY's -68.24%.
UTHR currently has the higher Sharpe Ratio (1.92 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTHR and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer